IVA logo
IVA NASDAQ FR

Inventiva S.A. - American Depository Shares

Healthcare · Biotechnology Website · IPO Feb 2017
$5.47
▲ +$0.04 (+0.74%)
Vol 322K
4
Quality Score
fail
Mkt Cap
$753.5M
ROE
-145.4%
Margin
-2284.9%
D/E
75.60
Beta
0.25
52W
$2–$6

Wall Street Consensus

16 analysts · Apr 2026
8
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
93.8%
Buy Rating

Price Chart

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -145.4% -145.4% -145.4% -145.4% -145.4%
P/E (TTM)
Net Margin -3951.5% -2002.8% -2002.8% -2285.4% -2285.4% -2284.9%
Gross Margin
D/E Ratio 75.60 75.60 75.60 75.60 75.60
Current Ratio 2.98 0.92 0.92 0.92 0.92 2.98

Key Ratios

ROA (TTM)
-208.7%
P/S (TTM)
55.36
P/B
4.5
EPS (TTM)
$-3.60
CF/Share
$-1.87
Rev Growth 3Y
+29.9%
52W High
$5.55
52W Low
$2.08
$2.08 52-Week Range $5.55

How does IVA compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

IVA valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
55.4
331% above peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
4.5
83% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

IVA profitability vs Biotechnology peers

ROE
-145.4%
116% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-2284.9%
697% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-208.7%
347% below peers (-46.7%)
vs Peers
vs Industry
Weak

IVA financial health vs Biotechnology peers

D/E ratio
75.6
0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
3.0
33% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.3
75% below peers (1.0)
vs Peers
vs Industry
More volatile

IVA fundamentals radar

IVA Peer median Industry

IVA profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

IVA vs peers: key metrics